Fig. 3
From: Sialyl-Tn serves as a potential therapeutic target for ovarian cancer
Development and testing of a custom ELISA. Panel A provides a schematic of the ELISA. Panel B illustrates the STn levels in serum collected from patients diagnosed with OvCa (all subtypes) compared to retrospective collected serum collected from patients diagnosed with benign conditions (endometriosis, uterine fibroids, follicular cysts etc.)